Report Categories
View AllRecent Articles
View All
CXW CoreCivic Inc reports fourth quarter 2025 EPS well above analyst estimates stock edges higher today
BFH Bread EPS surges 34 past estimates on cost discipline but flat revenue raises growth concerns
Is Summit SSBI a value trap or a value play Slight Uptick 20260508
OKYO OKYO Stock High Reward Trade 129 20260422
What Huize HUIZ disclosed about cost pressures Huize Posts Massive Loss Shares Under Pressure
RiverNorth RIV Stock This Week Idled 20260420
Grayscale Ethereum Staking ETF ETHE Positioned to Capture Ethereums Structural Upside Amid Crypto Market Rotation
Why Hayward Holdings HAYW Just Dropped 201 What to Watch 20260515
AB Muni Fund AFB Q3 2024 Earnings Revenue NA Matching Views
GEA Group Insider Buying Director Peter Lauwers Acquires Shares
Weibo WB Q3 2025 In Line Whats Next for Investors
Prime Medicine PRME Q1 2026 Disappoints EPS 028 Below 026 Views
Grab GRABW Flat at 004 Consolidation Continues 20260518
Wall Street Hits New Highs as AI Rally Takes a Breather
Suzlon Energy Q4 2026 Results Profit Dips 6 YoY on Higher Costs Revenue Surges 45
Russian Missile Attack on Ukraine Escalates Geopolitical Risks Raising Market Uncertainty
Time Magazine Proposes Path to Revitalize Global Trading System
Spains Youth Housing Crisis Renting Alone Now Costs 987 of Average Wage
Boston Red Sox Organizational Move Risks Franchise Value After Varitek Decision
Lineage Cell Therapeutics Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Continues Pipeline Investment
SUNation Energy Inc SUNE Q2 2024 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Revenue Uncertainty
KRYS Q1 2026 Earnings EPS Smashes Estimates Stock Edges Higher
GLIBK Q1 2026 Earnings EPS Falls Sharply Short of Consensus Stock Declines
BioTechne TECH Q1 2026 Earnings EPS Misses Estimates but Shares Edge Higher
PLRX Q1 2026 Earnings Narrowerthanexpected loss as clinical pipeline progresses
Canadian Solar CSIQ Hovers Near Support Amid Mild Selloff
Turtle Beach TBCH Inches Higher as Shares Test Resistance Above 13
Drugs Made In America Acquisition Corp Rights DMAAR Edges Higher Analyzing the 012 Level
Yatra Online YTRA Surges 6 as Buying Momentum Builds Near Key Support
DMIIR Rights Hover at 009 as Flat Trading Persists for Drugs Made In America Acquisition II Corp